123 related articles for article (PubMed ID: 16792834)
1. Prognostic importance of palpability as a feature of screen-detected breast cancers.
Gill G; Luke C; Roder D
J Med Screen; 2006; 13(2):98-101. PubMed ID: 16792834
[TBL] [Abstract][Full Text] [Related]
2. Interval breast cancers: prognostic features and survival by subtype and time since screening.
Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J
J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651
[TBL] [Abstract][Full Text] [Related]
3. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
4. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
5. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
[TBL] [Abstract][Full Text] [Related]
6. The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer.
Sweeney KJ; Kell MR; Aziz NA; Prunty N; Holloway P; Kennedy M; Flanagan F; Kerin MJ
Ir Med J; 2007 Sep; 100(8):550-2. PubMed ID: 17955686
[TBL] [Abstract][Full Text] [Related]
7. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
10. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
11. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
[TBL] [Abstract][Full Text] [Related]
12. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
13. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003.
Luke C; Gill G; Birrell S; Humeniuk V; Borg M; Karapetis C; Koczwara B; Olver I; Penniment M; Pittman K; Price T; Walsh D; Yeoh EK; Roder D
J Eval Clin Pract; 2007 Apr; 13(2):212-20. PubMed ID: 17378867
[TBL] [Abstract][Full Text] [Related]
14. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
15. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
16. Tumour size at detection according to different measures of mammographic breast density.
Nickson C; Kavanagh AM
J Med Screen; 2009; 16(3):140-6. PubMed ID: 19805755
[TBL] [Abstract][Full Text] [Related]
17. Screen-detected breast cancers have a lower mitotic activity index.
Groenendijk RP; Bult P; Tewarie L; Peer PG; van der Sluis RF; Ruers TJ; Wobbes T
Br J Cancer; 2000 Jan; 82(2):381-4. PubMed ID: 10646892
[TBL] [Abstract][Full Text] [Related]
18. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
19. Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based series.
Lundin J; Lehtimäki T; Lundin M; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Isola J; Joensuu H
Eur J Cancer; 2006 Dec; 42(18):3228-35. PubMed ID: 17015014
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer.
Burke JP; Power C; Gorey TF; Flanagan F; Kerin MJ; Kell MR
Eur J Surg Oncol; 2008 Feb; 34(2):149-53. PubMed ID: 17498912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
